Prosecution Insights
Last updated: October 25, 2026

Thomas J Visone, USPTO Patent Examiner

Listed by the USPTO as VISONE, THOMAS J

Tech Center 4100 • Art Units: 1600 1625 1641 1647 1651 1655 1671 1672 1674 1678

This examiner grants 56% of resolved cases

Analysis

VISONE, THOMAS J works in tech center 4100 and art unit 1600. The profile records 493 resolved cases, an allowance rate of 55.6%, and a median of 1092 days to allowance. The interview lift is 40.2%, showing a strong positive association between interviews and allowance outcomes.

The principal institutional clients are University of Massachusetts, Tohoku University, and Buddhist Tzu Chi Medical Foundation. The leading firms are BANNER & WITCOFF, LTD., DINSMORE & SHOHL LLP, and Lathrop GPM LLP. Practitioners can use the combination of allowance, timing, and interview data to plan prosecution in a setting where examiner interviews are materially associated with improved allowance outcomes.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

55.6%
Allow Rate
-4.4% vs TC avg
505
Total Applications
+40.2%
Interview Lift
1092
Avg Prosecution Days
Based on 493 resolved cases, 2023–2026

Rejection Statute Breakdown

7.7%
§101 Eligibility
8.8%
§102 Novelty
37.8%
§103 Obviousness
27.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18707207 WNT-MODULATING GENE SILENCERS AS BONE ANABOLIC THERAPY FOR OSTEOPOROSIS AND CRITICAL-SIZED BONE DEFECT Non-Final OA University of Massachusetts
18005537 PLURIPOTENT STEM CELLS EFFECTIVE FOR TREATMENT OF MOTOR NEURON DISEASE (MND) Non-Final OA TOHOKU UNIVERSITY
17821416 METHOD FOR TREATING OPTIC NEUROPATHY Final Rejection BUDDHIST TZU CHI MEDICAL FOUNDATION
18853149 A MESENCHYMAL STEM CELLS FORMULATION FOR COSMETIC USE Non-Final OA BRIGHT CELL, INC.
18557159 MYELOID-SPECIFIC PROMOTER AND USE THEREOF Non-Final OA BEIJING MEIKANG GENO-IMMUNE BIOTECHNOLOGY CO., LTD.
18341210 BOYSENBERRY COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF Non-Final OA The New Zealand Institute for Plant and Food Research Limited
18035342 TREATING OBSESSIVE-COMPULSIVE DISPORDER USING BOL-148 Final Rejection CERUVIA LIFESCIENCES LLC
18192674 METHOD AND SYSTEM FOR DELIVERING NUCLEIC ACID Final Rejection Hangzhou Songyin Biomedical Science and Technology Co., Ltd.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Thomas J Visone's allowance rate?

55.6% of resolved applications examined by Thomas J Visone were allowed (493 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.

Does an interview help with examiner Thomas J Visone?

This examiner's interview lift is +40.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Thomas J Visone take to allow a patent?

Applications allowed by Thomas J Visone took 1,092 days on average from filing to allowance.

Which art unit does examiner Thomas J Visone work in?

Thomas J Visone examines applications in Art Unit 1600 in Tech Center 4100.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month